Cargando…
Repurposing of medications for pulmonary arterial hypertension
This manuscript on drug repurposing incorporates the broad experience of members of the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative as an open debate platform for academia, the pharmaceutical industry and regulatory experts surrounding the future design of clinical...
Autores principales: | Toshner, Mark, Spiekerkoetter, Edda, Bogaard, Harm, Hansmann, Georg, Nikkho, Sylvia, Prins, Kurt W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682234/ https://www.ncbi.nlm.nih.gov/pubmed/33282182 http://dx.doi.org/10.1177/2045894020941494 |
Ejemplares similares
-
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
por: Prins, Kurt W., et al.
Publicado: (2018) -
Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2018) -
Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019) -
Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension
por: Han, Yun, et al.
Publicado: (2021) -
Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Bogaard, Harm J., et al.
Publicado: (2019)